Conservative Treatment of Postprostatectomy Incontinence
Urinary Incontinence
About this trial
This is an interventional treatment trial for Urinary Incontinence focused on measuring urinary incontinence, therapy, prostatectomy, prostate cancer
Eligibility Criteria
Inclusion Criteria: Involuntary loss of urine that started immediately after radical prostatectomy and has persisted for at least one year. One-week bladder diary with interpretable data and at least two incontinence episodes Exclusion Criteria: Any unstable medical condition, particularly decompensated congestive heart failure, history of malignant arrhythmias, or unstable angina Cardiac pacemaker or implanted cardiac defibrillator Current use of anticholinergic agents for detrusor instability Folstein's Mini-Mental State Exam score below 24 (impaired mental status) One-week bladder diary with continual leakage - defined as always being damp or wet or unable to quantitate individual accidents. Poorly controlled diabetes, defined as (glycosylated hemoglobin > 9 within last 3 months). Hematuria on microscopic examination. Enrollment will be permitted after urologic evaluation. Urodynamic evaluation: Post-void residual volume greater than 200 mL
Sites / Locations
- University of Alabama at Birmingham
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Experimental
Placebo Comparator
Behavioral Therapy
Behavioral Therapy Plus Technologies
Placebo Comparator
Behavioral Therapy (Pelvic floor muscle training, bladder control strategies)
Behavioral therapy plus technologies (home pelvic floor electrical stimulation and biofeedback)
No treatment control